Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01768325 · ClinicalTrials.gov registry record · NA
Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT01768325 is a NA study that has completed, run by Indiana University. The registered enrollment target is 85 participants.
The verdict
NCT01768325, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a new EUS-guided biopsy needle (ProCore®) comparing it to conventional EUS-TCB needle (Quick-Core®) in the diagnosis of your suspicious disorder. This study needle (ProCore®) is a new EUS-guided biopsy needle and has been recently approved by the U.S. Food and Drug Administration (FDA) for use.
Interventions
- DEVICE EUS-TCB needle (QuickCore) standard of care
- DEVICE EUS-Guided biopsy needle (ProCore)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01768325
The ClinicalTrials.gov registry entry for NCT01768325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EUS-TCB needle (QuickCore) standard of care is the first listed.
NCT01768325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01768325 about?
NCT01768325 is a clinical study titled "Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)". The purpose of this study is to evaluate a new EUS-guided biopsy needle (ProCore®) comparing it to conventional EUS-TCB needle (Quick-Core®) in the diagnosis of your suspicious disorder. This study needle (ProCore®) is a new EUS-guided biopsy needle and has been recently approved by the U.S. Food a...
What is the current status of trial NCT01768325?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2012-01. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01768325?
The interventions under investigation include: EUS-TCB needle (QuickCore) standard of care (DEVICE), EUS-Guided biopsy needle (ProCore) (DEVICE).
Who is sponsoring clinical trial NCT01768325?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.